Notre étude de la flore microbienne présente dans les différents liquides de dialyse montre la prédominance de bactéries à Gram négatif dont la paroi renferme des Lipopolysaccharides (LPS). Ces bactéries appartiennent essentiellement au genre <i>Pseudomonas</i>. L'étude de leur répartition selon l'origine des prélèvements indique que les deux espèces majoritaires <i>cepacia</i> et <i>testosteroni</i> sont également les plus ubiquitaires. La caractérisation biochimique des LPS de deux souches appartenant à ces deux espèces nous a permis de dégager les points suivants : (¤) L'analyse par électrophorèse en gel de polyacrylamide (DOCPAGE) ne montre pas de différence significative dans le comportement des LPS extraits selon les deux techniques les plus courantes : les LPS I par la technique P.C.P [Galanos <i>et al.</i>, 1969], et les LPS II par la technique au phénol aqueux [Westphal <i>et al.</i>, 1952]. Les deux souches présentent néanmoins des profils électrophorétiques très différents. Les LPS de P. cepacia 871101 possèdent, outre des LPS de forme R, une homogénéité de structure des LPS de forme S qui semble liée à l'existence d'une protéine cristalline au sein de la paroi [Dooley <i>et al.</i>, 1985]. Les LPS de P. testosteroni sont composés de LPS de forme R et de LPS de forme S qui possèdent des chaînes polysaccharidiques constituées d'un nombre réduit de sous-unités O-spécifiques. (¤) L'analyse de la composition biochimique met en évidence une homogénéité entre les LPS I et les LPS II. Nos résultats confirment certaines données de la littérature concernant les LPS de Pseudomonas [Wilkinson <i>et al.</i>, 1973, Kropinski <i>et al.</i>, 1985] : (#) la teneur en KDO est très variable selon les espèces et selon les souches au sein d'une même espèce ce qui semble indiquer que la partie "core" n'est pas aussi constante au sein du genre <i>Pseudomonas</i> que pour les différents genres bactériens qui composent la famille des Entérobactéries; (#) la quantité de glucosamine varie également selon l'espèce et selon la souche, ce qui traduit la présence d'oses aminés au niveau de la chaîne polysaccharidique de certains LPS susceptibles d'interférer dans le dosage; (#) la composition en oses neutres des LPS de <i>P. cepacia</i> 871101 rejoint les données de la littérature. En revanche, la souche 871204 de <i>P. testosteroni</i> présente deux particularités : une absence totale de rhamnose et la présence de fucose, sucre inhabituel des LPS de <i>Pseudomonas</i>; (#) nous avons trouvé la présence d'acide gras P-hydroxylé de type β-hydroxylaurique (C_12:0 OH₃), différent de celui retrouvé dans les LPS des Entérobactéries. Les études d'activités biologiques effectuées avec le test d'induction de la synthèse d'IL-1 font apparaître des activités spécifiques différentes selon les LPS et selon les souches. Cependant, aucune corrélation ne peut être effectuée entre ces deux tests car ils mettent en jeu des fonctions biologiques différentes : le test LAL fait appel à une fonction de type moléculaire alors que le test IL-1 fait appel à une fonction de type cellulaire. Les résultats de l'étude consacrée au passage des LPS à travers différents types de membranes montrent que pour les membranes d'ultrafiltration, le seuil de coupure nécessaire à la rétention de tout LPS susceptible de réagir avec le LAL et détectable en électrophorèse est de 8 Kda. Ils prouvent également à l'aide de LPS radioactifs (³H-LPS) que le transfert des LPS à travers trois membranes de dialyse du commerce survient dès les premières minutes de la simulation d'une séance de dialyse. Ceci indique que l'hypothèse impliquant les LPS comme l'origine des réactions anaphylactoïdes observées lors de certaines séances d'hémodialyse est confortée par la mise en évidence du passage de ces LPS à travers les membranes des hémodialyseurs du commerce.

Over the last decade, the innate immune system has been the subject of extensive research. Often overlooked by the robustness and specificity of the adaptive immune system, the innate immune system is proving to be just as complex. The identification of several families of pattern recognition receptors (PRRs) has revealed an ancient yet multifaceted system of proteins that are responsible for initiating host defense. A wide array of pathogens, from virus to bacteria, is detected using this assortment of receptors. One such family, the Toll-like receptors (TLRs), has been at the forefront of this research. To date, 10 TLRs have been described in the human genome. Activation of TLRs leads to the induction of immune-related genes that ultimately control the response of the host. However, the signaling pathways emanating from activated TLRs and other PRRs are not fully understood. In particular, the pathway leading to the activation of interferon regulatory factor 3 (IRF3), a transcription factor crucial for the induction of type I interferon, remains undefined. IRF3 activation occurs as the consequence of viral infection and through the activation of TLRs 3 and 4 by dsRNA and lipopolysaccharide (LPS), respectively. The focus of this research is to describe components of the IRF3 activation pathway, partly through the analysis of TLR signal transduction. IRF3 normally resides in the cytoplasm of cells. Upon infection with certain viruses and bacteria, IRF3 is activated though phosphorylation at its C-terminus. Phosphorylated IRF3 homodimerizes and associates with co-activators CBP-p300. After translocating to the nucleus, the activate IRF3 complex induces the activation of type 1 interferon and interferon related genes. Little is known about the pathways that lead to the activation of IRF3, especially the kinases involved. In this study we report that the non-canonical IкB kinase homologues, IкB kinase epsilon (IKKε) and TANK-binding kinase-1 (TBK1), which were previously implicated in NF-кB activation, are also essential components of the IRF3 signaling pathway. In particular, mouse embryonic fibroblasts from TBK1 deficient mice fail to activate IRF3 in response to both viral infection and stimulation with LPS or poly (IC), a dsRNA analog. Thus, both IKKε and TBK1 play a critical role in innate immunity and host defense. In addition to viral infection, IRF3 activation also occurs via the activation of TLR3 and 4. TLRs signal through a subfamily of Toll-IL-1-Resistance (TIR) domain containing adapter molecules. One such adapter, MyD88, is crucial for all TLRs, with the exception of TLR3. MyD88 participates in a signal transduction pathway culminating in the activation of the transcription factor NF-кB. Studies from MyD88-deficient mice reveal that both TLR3 and 4 still are capable of activating NF-кB, although with slightly delayed kinetics. Another aspect of the MyD88-independent signal transduction pathway is the activation of IRF3. A second TIR domain containing adapter molecule called Mal/Tirap was discovered and originally thought to mediate the MyD88-independent pathway. However, Mal-deficient mice were found to be defective in both TLR2 and 4 mediated NF-кB activation. We hypothesized that other TIR domain containing adapters could mediate this MyD88-independent pathway of TLR3 and 4 leading to the activation of IRF3. Two additional TIR adapters were discovered, TRIF and TRAM. TRIF was shown to mediate TLR3 signal transduction. In this study, we report that both TRIF and TRAM mediate the activation of the MyD88-independent pathway in response to LPS/TLR4 activation. Unlike any of the other known TIR domain containing adapters, TRAM appears to be restricted to the LPS/TLR4 activation pathway while TRIF plays a role in both TLR3 and TLR4 pathways leading to IRF3 target gene expression. Our studies revealed that TRAM could be acting upstream of TRIF in the LPS/TLR4 pathway. To this end, we sought to determine the localization of TRAM within the cell. We found that TRAM localizes to the plasma membrane. TRAM localization is the result of myristoylation since mutation of the predicted myristoylation site (G2A) resulted in the re-distribution of TRAM from the membrane into the cytoplasm. Reconstitution of TRAM-deficient macrophages with TRAM G2A is unable to rescue LPS/TLR4 signal transduction. Thus, myristoylation and membrane association of TRAM are critical for LPS/TLR4 signal transduction. The data generated in this dissertation extends our understanding of the signaling pathways of the innate immune system. Indeed, the molecules and pathways described herein could prove to be beneficial targets for ameliorating symptoms of disease, both autoimmune and pathogen-associated. Finally, the research described here will spur further insight into the complex signaling pathways of a once ignored arm of the immune system.

No description available.

Lipopolissacarídeos (LPS), pode tanto proteger quanto exacerbar o desenvolvimento da asma. LPS inicia a ativação da resposta imune via ligação da molécula Toll-like receptor 4 (TLR4) que sinaliza por duas vias distintas, as moléculas adaptadoras MyD88 e TRIF. LPS é um adjuvante que induz resposta do tipo Th1, enquanto que o hidróxido de alumínio (Alum) desperta respostas Th2, porém, a mistura de ambos adjuvantes na indução da resposta alérgica pulmonar ainda não foi investigada. No presente estudo, nós determinamos o efeito de dois agonistas de TLR4, um natural (LPS) e outro sintético (ER-803022) adsorvidos ao Alum sobre o desenvolvimento de doença alérgica pulmonar. Os animais foram sensibilizados pela via subcutânea com os antígenos, Ovoalbumina (OVA) ou Toxóide Tetânico (TT) na presença ou ausência de agonistas de TLR4 co-adsorvidos ao Alum e desafiados com os respectivos antígenos pela via intranasal. Nossos resultados mostraram que a sensibilização com OVA ou TT e LPS coadsorvidos ao Alum, impede o estabelecimento da resposta alérgica mediada por linfócitos Th2, tais como, influxo de eosinófilos, produção de citocinas do tipo 2, hiperreatividade brônquica, secreção de muco, e produção de IgE ou IgG1 anafilática. Apesar dos níveis de IgG2a, isotipo associado com as respostas Th1 estarem aumentados, análise da histopatologia pulmonar não revelou um desvio para o padrão Th1 de inflamação. Verificamos que a presença das moléculas TLR4, MyD88, IL-12/IFN-g mas não TRIF foram necessários para LPS exercer seu efeito inibitório. O agonista sintético de TLR4, menos tóxico que LPS, também protegeu contra o desenvolvimento de inflamação alérgica pulmonar. Em conclusão, nosso trabalho esclarece o efeito da sinalização do TLR4 na sensibilização alérgica e indica que agonista sintético de TLR4 com baixa toxicidade, pode ser utilizado para modular a capacidade adjuvante do Alum e conseqüentemente diminuir a indução de alergias. / Epidemiological and experimental data suggest that bacterial lipopolysaccharides (LPS) can either protect from or exacerbate allergic asthma. LPS triggers immune responses through Toll-like receptor (TLR) 4 that in turn activates two major signaling pathways via either MyD88 or TRIF adaptor proteins. LPS is a pro-Th1 adjuvant while aluminum hydroxide (Alum) is a strong Th2 adjuvant, but the effect of mixing both adjuvants on development of lung allergy has not been investigated. We determined whether natural (LPS) or synthetic (ER-803022) TLR4 agonists adsorbed onto alum adjuvant affect allergen sensitization and development of airway allergic disease. To dissect LPS-induced molecular pathways we used TLR4, MyD88, TRIF, or IL-12/IFN-g deficient mice. Mice were sensitized subcutaneously to allergens such as ovalbumin (OVA) or tetanus toxoid (TT) with or without TLR4 agonists coadsorbed onto Alum and challenged twice via intranasal route with the same allergens. The development of type 2 immunity was evaluated 24 h after last allergen challenge. We found that sensitization with OVA or TT plus LPS co-adsorbed onto Alum impaired allergeninduced Th2-mediated responses such as airway eosinophilia, type 2 cytokines secretion, airway hyperreactivity, mucus hyper production and serum levels of IgE or IgG1 anaphylactic antibodies. Although the levels of IgG2a, a Th1 affiliated isotype increased, investigation into the lung-specific effects revealed that LPS did not induce a Th1 pattern of inflammation. LPS impaired the development of Th2 immunity, signaling via TLR4 and MyD88 molecules via the IL-12/IFN-g axis, but not through TRIF pathway. Moreover, the synthetic TLR4 agonists that proved to have a less systemic inflammatory response than LPS also protected against allergic asthma development. TLR4 agonists co-adsorbed with allergen onto Alum down modulate Th2 immunity and prevent the development of polarized T cell-mediated airway inflammation. Thus, our work clarifies the effect of TLR4 signaling in allergic sensitization and indicates that TLR4 agonists with low toxicity might be useful for down regulating the pro-Th2 adjuvant activity of alum and consequently decrease the induction of allergy.

INTRODUÇÃO: O receptor tipo Toll 4 (TLR4) pertencente a uma família de receptores do sistema imune inato, reconhece o padrão molecular de lipopolissacarídeos (LPS), expressos por bactérias Gram negativas. Sua cascata de sinalização, nas células apresentadoras de antígeno, ocorre por duas vias principais: MyD88-dependente, que resulta na ativação de NF-B e na expressão de genes de resposta inflamatória e MyD88-independente, responsável pela ativação dos fatores IRF3 e IRF7, culminando na síntese de interferons e , envolvidos na resposta anti-viral e anti-bacteriana. Células não-imunes, de diversos tecidos, também expressam TLR4, incluindo células pancreáticas murinas e humanas. Devido ao seu papel nos processos inflamatórios, os TLR estão implicados em doenças crônicas como obesidade e diabetes. Estudo anterior do grupo identificou TLR4 como uma molécula que ativa sinais inflamatórios e provoca alterações na homeostase das células . Neste trabalho, investigamos qual via é ativada por LPS e quais os efeitos da expressão do TLR4 na viabilidade celular e na produção de insulina em células murinas. MÉTODOS: Células MIN6 (linhagem celular de insulinoma de camundongo) foram cultivadas em condições de hipo (2,8mM glicose), normo (5,6mM glicose) e hiperglicemia (11,2mM glicose), por 4 dias. Após esse período, foi adicionado LPS (50 ng/mL) por 48h e foram feitas análises por PCR em tempo real, Western Blot, ELISA e citometria de fluxo. RESULTADOS: Os resultados confirmam o aumento de TLR4 em células em condições de hiperglicemia e a via de sinalização ativada por LPS é a via MyD88-dependente, envolvida na produção de citocinas pró-inflamatórias. A via de indução de intérferons tipo 1 está ausente nestas células. Além disso, TLR4 ativado por LPS aumentou secreção de insulina em resposta a glicose, mas não induziu a morte celular. CONCLUSÃO: A expressão de TLR4 em células pancreáticas murinas é induzida em resposta ao aumento da glicemia, constituindo um novo elo entre a agressão à célula causada por altos níveis de glicose e a alteração da função celular induzida por LPS / INTRODUCTION: Toll-like receptor 4 (TLR4) belongs to a family of innate immunity receptors and recognizes the molecular pattern present in lipopolysaccharides (LPS), typical of Gram-negative bacteria. There are two TLR4 signaling pathways, typically in antigen-presenting cells: one is MyD88-dependent, activating NF-kB transcription factor and triggering inflammatory cytokine production and the other is MyD88-independent, leading to activation of IRF3 and IRF-7 and production of interferons e , involved in antiviral and antibacterial immune responses. Non-immune cells in several tissues also express TLR4, including human and murine pancreatic cells. Due to their role in inflammatory processes, TLRs have been implicated in chronic diseases like obesity and diabetes. Our previous study identified TLR4 as a molecule which activates inflammatory signals and induces changes in cell homeostasis. In this study, we investigated which of the TLR4 pathways is activated by LPS and the effects of glucose levels on cell viability and insulin production in a mouse insulinoma cell line. METHODS: MIN6 cells were maintained in low (2,8mM), normal (5,6mM) and high (11,2mM) glucose levels for 4 days, and then incubated with LPS (50 ng/mL) for 48 hours. Analyses were done by real-time PCR, Western Blot, ELISA and flow cytometry. RESULTS: Analysis confirmed increase in TLR4 gene expression in hyperglycemic conditions and showed that the signaling pathway activated by LPS is MyD88-dependent. The interferon induction pathway is absent in these cells. Furthermore, upon activation by LPS, TLR4 impacts on insulin secretion in response to glucose, but without triggering cell death. CONCLUSION: We conclude that TLR4 expression in mouse pancreatic cells is induced in response to increased glucose levels, constituting a new link in the chain of events leading to cell stress caused by high glucose levels with concomitant changes in cell function induced by LPS

Submitted by Renata Lopes (renatasil82@gmail.com) on 2016-02-26T13:39:38Z No. of bitstreams: 1 aydramendesalmeidabianchi.pdf: 1447064 bytes, checksum: 5e432ac627c643fd1832440690fe8539 (MD5) / Approved for entry into archive by Adriana Oliveira (adriana.oliveira@ufjf.edu.br) on 2016-03-03T14:05:06Z (GMT) No. of bitstreams: 1 aydramendesalmeidabianchi.pdf: 1447064 bytes, checksum: 5e432ac627c643fd1832440690fe8539 (MD5) / Made available in DSpace on 2016-03-03T14:05:06Z (GMT). No. of bitstreams: 1 aydramendesalmeidabianchi.pdf: 1447064 bytes, checksum: 5e432ac627c643fd1832440690fe8539 (MD5) Previous issue date: 2015-03-09 / FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais / Introdução: A posição prona tem sido estudada como estratégia ventilatória em pacientes com síndrome do desconforto respiratório agudo. Seus benefícios, inclusive com redução da mortalidade, estão bem estabelecidos nas formas graves da síndrome, mas não em formas mais leves. Objetivo: Investigar o efeito da posição prona nas trocas gasosas, inflamação e histologia pulmonar, em modelo experimental de lesão pulmonar aguda leve em ratos. Métodos: A lesão pulmonar aguda foi induzida em ratos Wistar, machos, adultos, através da injeção de lipopolissacarídeo da Escherichia coli (5 mg/Kg). Após 24 h, os animais com PaO2/FIO2 entre 200 e 300 mmHg foram anestesiados e randomizados dentro de 2 grupos de acordo com a sua posição durante a ventilação (prona [n=6] e supina [n=6]). Ambos os grupos foram comparados com um grupo controle [n=5] que recebeu solução salina a 0,9% intraperitoneal e foi ventilado em posição supina. Todos os grupos foram ventilados por 1 h em modo ventilatório volumecontrolado, com volume corrente de 6 ml/Kg, frequência respiratória de 80 irpm, pressão positiva ao final da expiração de 5 cmH2O e uma fração inspirada de oxigênio de 1. Resultados: O escore de lesão pulmonar foi significativamente maior no grupo LPS-supino, em comparação com os grupos LPS-prono e controle (0,32 ± 0,03; 0,17 ± 0,03 e 0,13 ± 0,04, respectivamente) (p < 0,001), devido a uma maior infiltração de neutrófilos no espaço intersticial e maior presença de debris proteicos na luz alveolar. Esta maior lesão pulmonar no grupo LPS-supino foi observada tanto nas regiões pulmonares dependentes da gravidade (dorsal no grupo supino e ventral no grupo prono – 0,34 ± 0,05 e 0,22 ± 0,04, respectivamente) (p < 0,05), quanto nas não dependentes (ventral no grupo supino e dorsal no grupo prono – 0,29 ± 0,04 e 0,13 ± 0,04, respectivamente) (p < 0,05). O contagem de neutrófilos no LBA foi maior no grupo LPS-supino, comparado com os grupos LPS prono e controle. Não houve diferenças significativas na relação peso úmido/peso seco e nas trocas gasosas entre os três grupos. Conclusões: Neste modelo experimental de lesão pulmonar aguda leve extrapulmonar, a ventilação em posição prona por 1 hora, quando comparada com a ventilação em posição supino, associou-se a menor lesão e inflamação pulmonar, mas sem impacto na oxigenação arterial e no edema pulmonar. / Introduction: Prone position has been studied as a ventilator strategy among patients with acute respiratory distress syndrome. The benefits of prone position ventilation, including reduction in the mortality, are well demonstrated in the severe but not in milder forms of this syndrome. We therefore investigated the effects of the prone position on arterial blood gases, lung inflammation and histology in an experimental model of mild acute lung injury in rats. Methods: Acute lung injury was induced in adult male Wistar rats by intraperitoneal Escherichia coli lipopolysaccharide injection (5 mg/kg). After 24h, the animals with PaO2/FIO2 between 200 and 300 mmHg were anesthetized and randomized into 2 groups according to their position during ventilation (prone [n=6] and supine [n=6]). Both groups were compared to a control group (n=5) that received intraperitoneal saline and was ventilated in the supine position. All of the groups were ventilated for 1h with volume-controlled ventilation mode, with tidal volume of 6 ml/kg, respiratory rate of 80 breaths/min, positive end-expiratory pressure of 5 cmH2O, and an inspired oxygen fraction of 1. Results: Significantly higher lung injury scores were observed in the LPS-supine group compared to LPS-prone and control groups (0.32 ± 0.03; 0.17 ± 0.03 and 0.13 ± 0.04, respectively) (p<0.001), mainly due to a higher neutrophil infiltration level in the interstitial space and more proteinaceous debris in the airspaces. Similar differences were observed when the gravitational dependent lung regions (dorsal in the supine group and ventral in the prone group – 0.34 ± 0.05 and 0.22 ± 0.04, respectively) (p < 0.05) and non-dependent lung regions (ventral in the supine group and dorsal in the prone group – 0.29 ± 0.04 and 0.13 ± 0.04, respectively) (p < 0.05) were analyzed separately. The BAL neutrophil content was also higher in the LPS-supine group compared to the LPSprone and control groups. There were no significant differences in the wet/dry ratio and gas exchange levels among the three groups. CONCLUSIONS: In this experimental extrapulmonary mild acute lung injury model, prone position ventilation for 1 hour, when compared with supine position ventilation, was associated with lower lung inflammation and injury, but without any impact on arterial oxygenation and lung edema.

Submitted by Renata Lopes (renatasil82@gmail.com) on 2016-01-11T17:31:37Z No. of bitstreams: 1 lidiamariacarneirodafonseca.pdf: 814638 bytes, checksum: 8aa87e2816d8e7e5c474900ab0798b04 (MD5) / Approved for entry into archive by Adriana Oliveira (adriana.oliveira@ufjf.edu.br) on 2016-01-25T17:10:03Z (GMT) No. of bitstreams: 1 lidiamariacarneirodafonseca.pdf: 814638 bytes, checksum: 8aa87e2816d8e7e5c474900ab0798b04 (MD5) / Made available in DSpace on 2016-01-25T17:10:03Z (GMT). No. of bitstreams: 1 lidiamariacarneirodafonseca.pdf: 814638 bytes, checksum: 8aa87e2816d8e7e5c474900ab0798b04 (MD5) Previous issue date: 2015-07-16 / FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais / Introdução: A forma como pulmões com enfisema respondem a uma agressão sistêmica como a sepse não é conhecida. É possível que as alterações inflamatórias e estruturais nos pulmões com enfisema alterem a resposta dos mesmos à sepse influenciando no desenvolvimento da síndrome do desconforto respiratório agudo. Objetivo: Comparar a lesão pulmonar secundária à sepse, induzida por lipopolissacarídeo (LPS) intraperitoneal, em ratos com e sem enfisema induzido pela administração intratraqueal de elastase. Métodos: Vinte e quatro ratos Wistar adultos foram randomizados para quatro grupos de seis animais: controle (C-C), enfisema (E-C), controle com sepse (C-LPS) e enfisema com sepse (E-LPS). O enfisema foi induzido pela injeção intratraqueal de elastase pancreática de porco (12 UI/ animal). Após três semanas deste procedimento, a sepse foi induzida pela injeção intraperitoneal de LPS da Escherichia coli (10 mg/Kg). Vinte e quatro horas após a indução da sepse, os animais foram submetidos à ventilação mecânica por 10 minutos para posterior coleta da gasometria arterial. A seguir, foram eutanasiados e as seguintes análises foram realizadas: lavado broncoalveolar (LBA), permeabilidade pulmonar e histologia. Os resultados foram expressos em média ± desvio padrão ou mediana (intervalo interquartil), quando apropriado, e comparados por ANOVA seguida do teste de Tukey, ou por Kruskal-Wallis seguido do teste de Mann-Whitney. Resultados: O escore de lesão pulmonar foi significativamente maior nos grupos C-LPS [0,62 (0,19)] e E-LPS [0,59 (0,13)] em comparação com os grupos C-C [0,11 (0,09)] e E-C [0,15 (0,05)] (p < 0,05). A contagem total de células (C-LPS=2,37 ± 0,74; E-LPS=5,37 ± 0,13; C-C=0,73 ± 0,36; E-C=3,09 ± 7,53 x 105) e de neutrófilos [C-LPS=1,39 (1,48); E-LPS=4,39 (1,95); C-C=0,07 (0,11); E-C=0,68 (0,61) x 105] no LBA foi significativamente maior nos grupos C-LPS e E-LPS comparado aos grupos C-C e E-C (p < 0,05). Animais do grupo E-LPS apresentaram maior contagem de células totais e de neutrófilos no LBA em comparação com o grupo C-LPS (p < 0,05). Na avaliação da razão albumina LBA/soro, o grupo E-LPS apresentou aumento significativo quando comparado ao C-LPS [0,069 (1,243) vs. 0,007 (0,002), respectivamente, p < 0,05]. Não foram observadas diferenças significativas nas trocas gasosas entre os grupos. Conclusões: A presença de enfisema foi acompanhada de maior inflamação pulmonar em resposta à agressão sistêmica induzida pela injeção intraperitoneal de LPS, levando a uma maior lesão da barreira alvéolo-capilar. Palavras-chave: enfisema pulmonar, sepse, lesão pulmonar aguda, síndrome do desconforto respiratório agudo, elastase pancreática, lipopolissacarídeos. / Introduction: The response of lungs with emphysema to a systemic insult such as sepsis is not known. Structural and inflammatory abnormalities in lungs caused by emphysema might alter their response to sepsis and thus influence the incidence and severity of acute respiratory distress syndrome. We therefore aimed to compare the severity and extension of acute lung injury in response to intraperitoneal lipopolysaccharide (LPS) injection in rats with and without emphysema induced by elastase. Methods: Twenty four adult Wistar rats were randomized into 4 groups, each of them with 6 animals: control (C-C), emphysema without sepsis (E-C), control with sepsis (C-LPS) and emphysema with sepsis (E-LPS). Emphysema was induced by intratracheal instillation of pancreatic porcine elastase (12 IU/animal). Three weeks later, sepsis was induced by intraperitoneal Escherichia coli LPS injection (10 mg/kg). Twenty four hours after sepsis induction, animals underwent mechanical ventilation for 10 minutes and then blood was sampled for gasometric analysis. Thereafter, euthanasia and the following analysis were performed: BAL, lung permeability and histology. Results were expressed as mean ± standard deviation or median (interquartile range), when appropriate, and compared using ANOVA followed by Tukey test or Kruskal-Wallis followed by Mann-Whitney test. Results: Significant increase in lung injury score was observed in the C-LPS [0.62 (0.19)] and E-LPS [0.59 (0.13)] compared to the groups C-C [0.11 (0.09)] and E-C [0.15 (0.05)] (p < 0.05). Total cell (C-LPS=2.37 ± 0.74; E-LPS=5.37 ± 0.13; C-C=0.73 ± 0.36; E-C=3.09 ± 7.53 x 105) and neutrophil counts [C-LPS=1.39 (1.48); E-LPS=4.39 (1.95); C-C=0.065 (0.11); E-C=0.68 (0.61) x 105] in the BAL were significantly higher in the groups that received LPS (p < 0.05). Significantly higher total cell and neutrophil counts in the BAL were also observed in the E-LPS group compared to C-LPS (p < 0.05). The group E-LPS showed a significant increase in the BAL/serum albumin ratio compared to C-LPS [0.069 (1.243) vs. 0.007 (0.002), respectively] (p < 0.05). There were no significant differences in the gas exchange levels among the groups. Conclusions: The presence of emphysema increases the inflammatory response in the lungs to a systemic stimulus, represented in this model by the intraperitoneal injection of LPS.

Once seen as a disease of wealthy nations, type 2 diabetes mellitus is now showing unprecedented growth throughout the world, fueling increases in microvascular and macrovascular complications. A compelling and growing body of evidence suggests that glucose intolerance and insulin resistance, hallmarks of the diabetic patient, may be driven by chronic inflammation. In particular, a predominance of visceral fat has been associated with enhanced inflammatory cytokine secretion that may contribute to enhanced risk of diabetes and comorbid cardiovascular disease in these individuals. As a function of its potency and wide environmental and biological distribution, we hypothesized that bacterial lipopolysaccharide (LPS, also known as endotoxin) may promote adipose inflammation and concomitant metabolic dysfunction. Indeed, expression of the LPS receptor CD14 is enhanced on visceral adipocytes of ob/ob mice, paralleling enhanced IL-6 secretion ex vivo. Furthermore, rosiglitazonefed ob/obmice demonstrated a reduction in CD14 that coordinated with diminished IL-6 secretion, suggesting a basis for the touted anti-inflammatory effects of this commonly employed type 2 diabetes medication. Mice deficient in components of the LPS signaling cascade, namely CD14, TLR4, and MyD88, yielded adipocytes with markedly attenuated IL-6 secretion, corroborating the central importance of LPS in adipocyte inflammation and supporting the role of this signaling pathway in depot-specific inflammation. Despite the prominent role of LPS signaling in adipocyte inflammation, CD14-, TLR4-, and MyD88-deficient mice failed to show resistance to diet induced obesity. Surprisingly, cd14-/- and tlr4-/- mice had marked glucose intolerance without alteration in total weight or adipose accumulation. In contrast, myd88-/- mice revealed minor glucose intolerance only with high fat diet challenge at an advanced age despite being overtly obese. In cd14-/- and tlr4-/-, but not myd88-/-, mice, an exaggerated rebound to hypoglycemia was associated with enhanced norepinephrine secretion, which could be abrogated by the adrenergic β-blocker propranolol. The overlay of these mouse models reveals a divergence of phenotypes that demonstrate LPS signaling disruption may lead to glucose intolerance and insulin resistance in part due to enhanced sympathoadrenal tone, uncovering an essential role of innate immunity in physiological stress and its impact upon glucose homeostasis.

No description available.

SUMMARY:<p>The bacterial lipopolysaccharide (LPS)-sensing machinery with the innate immune system receptor Toll-like receptor 4 (TLR4) at its centre has been the subject of extensive research but while TLR4 and myeloid differentiation factor 2 (MD2) were both shown to be essential, the role of other, so-called "accessory", molecules is much less clear. The co-receptor cluster of differentiation 14 (CD14) has been widely perceived as being a mere facilitator for the capture and transfer of LPS to TLR4, until recent studies suggested it might have a determining influence on which TLR4-dependent signaling cascades are triggered in response to LPS. The TLR4 receptor complex was shown to be specifically activated by diC14 amidine, a cationic lipid originally synthesized for its carrier properties. The lipid's immunostimulatory activity extends to both TLR4-dependent signaling cascades, the MyD88 and TRIF pathways.<p>The aim of this work was to gain more insight into how diC14 amidine is able to trigger these cascades and to contribute to the general understanding of the TLR4 machinery and its activation by non-LPS ligands. More precisely we were interested in the role of CD14 in the activation of both MyD88 and TRIF pathways by diC14-amidine and in potential consequences of possible divergent requirements of diC14 amidine and LPS for this co receptor.<p>Our study of the role of the membrane-associated and the soluble form of CD14 in the activation of the TLR4-dependent pathways by diC14 amidine revealed that – unlike LPS – the cationic lipid does not require CD14 to exercise its immunostimulatory activity, although the presence of the co receptor modulates the TLR4 activation and infrared spectroscopy experiments suggest a direct interaction.<p>In the case of sensing LPS, CD14 is required for the endocytosis of TLR4 and the subsequent activation of the TRIF pathway. By blocking the endocytosis mechanism at different stages we found that diC14-amidine generally enters the cell via endocytosis and that it activates – unlike LPS – both signaling cascades from inside endosomal vesicles, albeit at different stages of the endocytosis process.<p>Although the eventual immunological responses caused by diC14 amidine and LPS resemble each other or are even identical, our research revealed differences in the actual mechanism of activating TLR4, the receptor responsible for the corresponding innate immune response. These findings illustrate the uniqueness of diC14 amidine and the potential of further exploring its intriguing properties and mechanisms as a tool to decipher the TLR4 signaling machinery and with the perspective of designing new immunomodulators for vaccination and therapy.<p><p><p>RÉSUMÉ:<p>Le mécanisme de reconnaissance des lipopolysaccharides bactériens (LPS) par le récepteur de l'immunité innée Toll-like receptor 4 (TLR4) a fait l'objet d'une recherche intensive ces dernières années. Alors que TLR4 et son co-récepteur myeloid differentiation factor 2 (MD2) ont été démontrés comme étant essentiels pour la détection du LPS, le rôle des molécules dites "accessoires" est beaucoup moins évident. Le co-récepteur cluster of differentiation 14 (CD14) a largement été considéré comme un simple facilitateur pour la capture et le transfert des LPS à TLR4, mais des études récentes suggèrent qu'il pourrait avoir une influence déterminante sur les cascades de signalisation dépendantes de TLR4 induites en réponse au LPS. La diC14-amidine, un lipide cationique synthétisé initialement pour ses qualités en tant que vecteur de transfection, a révélé récemment une activité immunostimulatrice dépendante du récepteur TLR4, impliquant les deux cascades de signalisation dépendantes de TLR4, les voies MyD88 et TRIF.<p>Le but de ce travail était de mieux comprendre le mécanisme par lequel la diC14¬ amidine induit ces cascades et de contribuer à la compréhension générale du fonctionnement du complexe récepteur TLR4 et son activation par des ligands non-LPS. Plus précisément nous nous sommes intéressés au rôle de CD14 dans l'activation des voies MyD88 et TRIF par la diC14-amidine et des conséquences potentielles d’éventuelles divergences en termes d’exigence pour ce co-récepteur entre la diC14-amidine et le LPS. <p>Notre étude sur le rôle de la forme membranaire ou soluble de CD14 dans l'activation des voies dépendantes de TLR4 par la diC14-amidine a révélé que - contrairement au LPS - le lipide cationique ne nécessite pas de CD14 pour exercer son activité immunostimulatrice. Cependant, la présence du co-récepteur module l'activation de TLR4 et des expériences de spectroscopie infrarouge suggèrent une interaction directe entre le lipide et le CD14. <p>Dans le cas de la détection de LPS, le CD14 est nécessaire pour l'endocytose de TLR4 et l'activation subséquente de la voie TRIF. En bloquant le mécanisme d'endocytose à différents stades, nous avons montré que la diC14-amidine active - contrairement au LPS - les deux cascades de signalisation depuis l'intérieur des vésicules endosomiales, mais à des stades différents du processus d'endocytose.<p>En conclusion, bien que les réponses immunologiques causées par la diC14-amidine et le LPS se ressemblent, notre recherche a mis en évidence des différences substantielles dans leurs modes d'action. Ces différences illustrent le caractère unique de la diC14-amidine et son potentiel comme outil pour explorer la complexité du système de signalisation du TLR4 et en tirer des enseignements qui permettront de contribuer à la conception de nouveaux immunomodulateurs pour la vaccination et la thérapie. / Doctorat en Sciences / info:eu-repo/semantics/nonPublished